B’ZEOS SECURES SEED ROUND AND STRATEGIC PARTNERSHIPS

B’ZEOS secures seed round and strategic partnerships. B’ZEOS, a European blue-tech innovation company, has successfully closed their seed round led by Faber, with participation from ICIG Ventures, the venture capital unit of International Chemical Investors Group (ICIG). This achievement marks a significant milestone in their mission to scale up their innovative, compostable seaweed-based packaging solutions.

This latest round builds on previous funding from pre-seed biotech investor biotope by VIB, ocean-tech accelerator Sustainable Ocean Alliance (SOA), and private and public grants from the Research Council of Norway, Global Seaweed Coalition, Innovation Norway, and the Eureka Network’s Eurostars programme.

B’ZEOS said:

“Our partnership with Faber and ICIG empowers us to accelerate product development, meet industry demands more swiftly, and initiate commercial production with our corporate partners. Faber’s commitment to advancing ocean-based technologies makes them an ideal investment partner for us. Additionally, our collaboration with ICIG—a privately owned industrial group with expertise in biotechnology and novel materials—enables us to fine-tune our products and increase production using ICIG’s extensive knowledge in compounds.

“At B’ZEOS, we have developed seaweed-based solutions that are fully bio-based, home-compostable, and compatible with existing packaging production lines. Seaweed is an incredible raw material for sustainable packaging: it grows rapidly, sequesters CO2, requires no land or fresh water, and doesn’t release microplastics. Our materials’ versatility supports a wide range of applications across sectors, helping our corporate partners achieve their sustainability goals.

“Our packaging solutions have been validated through five paid pilot projects, including collaborations with industry leaders such as Nestlé. With the additional funding, we will continue participating in pilot schemes to demonstrate the value of our solutions, potentially reaching test-shop readiness with our partners. This funding will also enable us to advance from TRL7 to TRL8, bringing us closer to full commercialisation.”

Source